According to a research report titled ‘Global Bone Marrow Transplant Market 2019-2027’ available with Market Study Report, global bone marrow transplant market is anticipated to expand at 5.13% CAGR through the forecast period 2019-2027.
 

As per report findings, rising prevalence of blood tumors and anemia serves as a major growth impetus for global bone marrow transplant market. Moreover, increased survival rates after treatment and expanding bone marrow transplant registries are rendering a positive impact on the industry.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2486927/
 

Furthermore, developments in technology, rising per capita medicinal expenditure, as well as improving healthcare infrastructure are fueling the market development, cites the study.
 

Elaborating on the challenges prevailing in global bone marrow transplant market sphere, dearth of bone marrow donation, uncertainty of repayment, and heavy treatment expenses are likely to impede business progression during the upcoming years.
 

By transplant type, the market is fragmented into autologous and allogeneic. Based on indication, the industry segmentation comprises acute leukemia, multiple myeloma, non-Hodgkin lymphoma, Hodgkin lymphoma and solid tumors. Moving on, the end user scope segment constitutes hospitals, multispecialty clinics, and ambulatory surgical centers.
 

Considering the regional outlook, global bone marrow transplant market research covers North America, the Middle East and Africa, Asia Pacific, Latin America, and Europe. Among these, Europe accounted for a significant market share in the recent past owing to a substantial increase in the number of bone marrow transplant centers and extending bone marrow registries.
 

Whereas Latin America is anticipated to record high volume growth in forthcoming years, due to rising number of potential candidates opting for the procedure.
 

Meanwhile, North America bone marrow transplant industry is estimated record substantial growth in the upcoming years. This can be ascribed to increasing number of bone marrow transplant groups. Parallelly, Asia Pacific region, is projected to record remarkable growth despite the lack of donors and the high costs associated with the industry.
 

Key contenders in global bone marrow transplant market are Abbott Laboratories, Agendia N.V., Ambrilia Biopharma Inc., Affymetrix Inc., Agilent Technologies Inc., Diadexus, Inc., Astellas Pharma Inc., Roche Diagnostics Corporation, Illumina Inc., Stryker Corporation, Qiagen N.V., and Sanofi S.A.